In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein

In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein

The etiological agent of some anogenital tract cancers is infection with the high-risk human papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated, but the presence of drug treatment directed against the infection and its oncogenic effects remain essential. Among the...

Full description

Bibliographic Details
Main Authors:	Moujane Soumia, Halima Hajji, Mohamed El Mzibri, Filali Zegzouti Younes, Bouachrine Mohammed, Benlyas Mohamed, Moualij Benaissa
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Vaccines
Subjects:	cervical cancer MD simulations docking virtual screening E6-E6AP ADMET properties
Online Access:	https://www.mdpi.com/2076-393X/10/9/1452

Similar Items

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Computational assessment of the reactivity and pharmaceutical potential of novel triazole derivatives: An approach combining DFT calculations, molecular dynamics simulations, and molecular docking
by: Kamal Tabti, et al.
Published: (2024-01-01)

In silico screening and molecular dynamics simulations toward new human papillomavirus 16 type inhibitors
by: Nima Razzaghi-Asl, et al.
Published: (2022-01-01)

Garlic as an effective antifungal inhibitor: A combination of reverse docking, molecular dynamics simulation, ADMET screening, DFT, and retrosynthesis studies
by: Soukaina Bouamrane, et al.
Published: (2024-03-01)

Comparison of the binding energies of approved mpox drugs and phytochemicals through molecular docking, molecular dynamics simulation, and ADMET studies: An in silico approach
by: Ranjan K. Mohapatra, et al.
Published: (2023-09-01)

In vitro antioxidant and cytotoxicity activities and in silico anticancer property of methanolic leaf extract of Leucas indica
by: Tasmina Ferdous Susmi, et al.
Published: (2022-01-01)

Exploring the anticancer and antibacterial potential of naphthoquinone derivatives: a comprehensive computational investigation
by: Mehnaz Hossain Meem, et al.
Published: (2024-02-01)

Catastrophic Collision Between Obesity and COVID-19 Have Evoked the Computational Chemistry for Research in Silico Design of New CaMKKII Inhibitors Against Obesity by Using 3D-QSAR, Molecular Docking, and ADMET
by: Halima Hajji, et al.
Published: (2021-10-01)

Bioinformatics analysis of photoexcited natural flavonoid glycosides as the inhibitors for oropharyngeal HPV oncoproteins
by: Maryam Pourhajibagher, et al.
Published: (2024-03-01)

Exploring the Natural Compounds in Flavonoids for Their Potential Inhibition of Cancer Therapeutic Target MEK1 Using Computational Methods
by: Wejdan M. AlZahrani, et al.
Published: (2022-02-01)

HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression
by: Ye-Fei Chang, et al.
Published: (2021-10-01)

The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells
by: Yinghui Wang, et al.
Published: (2021-12-01)

In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions
by: Abdullahi Bello Umar, et al.
Published: (2020-09-01)

Computational Approaches for Identification of Potential Plant Bioactives as Novel G6PD Inhibitors Using Advanced Tools and Databases
by: Rana M. Aldossari, et al.
Published: (2023-03-01)

ADMET profiling and molecular docking of pyrazole and pyrazolines derivatives as antimicrobial agents
by: Fatima EN-NAHLI, et al.
Published: (2023-11-01)

Editorial: Use of computational tools for designing epigenetic drugs
by: Yudibeth Sixto-López, et al.
Published: (2024-02-01)

Neuroprotective Properties of Bis-Sulfonamide Derivatives Against 6-OHDA-Induced Parkinson's Model via Sirtuin 1 Activity and in silico Pharmacokinetic Properties
by: Setthawut Apiraksattayakul, et al.
Published: (2022-07-01)

Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties
by: Abdullahi Bello Umar, et al.
Published: (2020-10-01)

Do or Die: HPV E5, E6 and E7 in Cell Death Evasion
by: Josipa Skelin, et al.
Published: (2022-09-01)

UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells
by: Yanyan Luo, et al.
Published: (2023-09-01)

A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis
by: Jingwen Zhang, et al.
Published: (2022-03-01)

Utilization of computational methods for the identification of new natural inhibitors of human neutrophil elastase in inflammation therapy
by: Alzain Abdulrahim A., et al.
Published: (2023-11-01)

mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations
by: Qiqi Huang, et al.
Published: (2023-08-01)

Investigation of Antidepressant Properties of Yohimbine by Employing Structure-Based Computational Assessments
by: Munazzah Tasleem, et al.
Published: (2021-10-01)

Probing the potential of bioactive compounds of millets as an inhibitor for lifestyle diseases: molecular docking and simulation-based approach
by: Kajal Nagre, et al.
Published: (2023-09-01)

Molecular modeling in drug discovery
by: Temitope Isaac Adelusi, et al.
Published: (2022-01-01)

Regulation of O-Linked N-Acetyl Glucosamine Transferase (OGT) through E6 Stimulation of the Ubiquitin Ligase Activity of E6AP
by: Kangli Peng, et al.
Published: (2021-09-01)

Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18
by: Yakelin Díaz-Tejeda, et al.
Published: (2021-07-01)

E6/E7 and E6* From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
by: Cristina Artaza-Irigaray, et al.
Published: (2019-07-01)

hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization
by: Li Song, et al.
Published: (2022-06-01)

Synthesis, antibacterial evaluation, in silico ADMET and molecular docking studies of new N-acylhydrazone derivatives from acridone
by: Mohammed Aarjane, et al.
Published: (2020-07-01)

HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins
by: Soyeong Park, et al.
Published: (2021-02-01)

Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China
by: Jiaoyu He, et al.
Published: (2019-05-01)

Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols
by: Bhawna Sharma, et al.
Published: (2022-09-01)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
by: Tijana Bojić, et al.
Published: (2022-04-01)

In silico prediction and structure-based multitargeted molecular docking analysis of selected bioactive compounds against mucormycosis
by: Premnath Madanagopal, et al.
Published: (2022-01-01)

In Silico Studies of Two Biphenyl Based Oxime Containing Ligands
by: Bülent Dede, et al.
Published: (2021-11-01)

HPV-mediated down-regulation of NOD1 inhibits apoptosis in cervical cancer
by: Xubin Liu, et al.
Published: (2020-01-01)

The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation
by: Leonardo Fernandez-Avila, et al.
Published: (2023-09-01)

Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations
by: Hind Yassmine Chennai, et al.
Published: (2024-03-01)